Julia P Gregory - Net Worth and Insider Trading

Julia P Gregory Net Worth

The estimated net worth of Julia P Gregory is at least $1 Million dollars as of 2024-11-13. Julia P Gregory is the Director of Biohaven Ltd and owns about 25,665 shares of Biohaven Ltd (BHVN) stock worth over $1 Million. Julia P Gregory is the CEO of ContraFect Corp and owns about 63 shares of ContraFect Corp (CFRXQ) stock worth over $0. Julia P Gregory is also the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $0. Details can be seen in Julia P Gregory's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Julia P Gregory has not made any transactions after 2022-10-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Julia P Gregory

To

Julia P Gregory Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Julia P Gregory owns 5 companies in total, including Nurix Therapeutics Inc (NRIX) , Biohaven Pharmaceutical Holding Co Ltd (BHVN) , and ContraFect Corp (CFRXQ) among others .

Click here to see the complete history of Julia P Gregory’s form 4 insider trades.

Insider Ownership Summary of Julia P Gregory

Ticker Comapny Transaction Date Type of Owner
NRIX Nurix Therapeutics Inc 2020-07-23 director
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-12-20 director
CFRXQ ContraFect Corp 2015-03-02 CEO
LIMIT LIMIT 2003-12-26 EVP & Corp Dev and CFO
LIMIT LIMIT 2022-10-25 director

Julia P Gregory Latest Holdings Summary

Julia P Gregory currently owns a total of 3 stocks. Among these stocks, Julia P Gregory owns 25,665 shares of Biohaven Ltd (BHVN) as of October 25, 2022, with a value of $1 Million and a weighting of 100%. Julia P Gregory owns 63 shares of ContraFect Corp (CFRXQ) as of March 2, 2015, with a value of $0 and a weighting of 0%. Julia P Gregory also owns 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of December 20, 2021, with a value of $0 and a weighting of 0%.

Latest Holdings of Julia P Gregory

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHVN Biohaven Ltd 2022-10-25 25,665 50.36 1,292,489
CFRXQ ContraFect Corp 2015-03-02 63 0.00 0
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-12-20 0 14.08 0

Holding Weightings of Julia P Gregory


Julia P Gregory Form 4 Trading Tracker

According to the SEC Form 4 filings, Julia P Gregory has made a total of 1 transactions in Biohaven Ltd (BHVN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Biohaven Ltd is the acquisition of 9,523 shares on October 25, 2022, which cost Julia P Gregory around $99,992.

According to the SEC Form 4 filings, Julia P Gregory has made a total of 0 transactions in ContraFect Corp (CFRXQ) over the past 5 years. The most-recent trade in ContraFect Corp is the acquisition of 15 shares on March 2, 2015, which cost Julia P Gregory around $54,297.

According to the SEC Form 4 filings, Julia P Gregory has made a total of 2 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 12,000 shares on December 20, 2021, which brought Julia P Gregory around $2 Million.

Insider Trading History of Julia P Gregory

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Julia P Gregory Trading Performance

GuruFocus tracks the stock performance after each of Julia P Gregory's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Julia P Gregory is 20.37%. GuruFocus also compares Julia P Gregory's trading performance to market benchmark return within the same time period. The performance of stocks bought by Julia P Gregory within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Julia P Gregory's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Julia P Gregory

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 20.11 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 19.14 LIMIT LIMIT LIMIT LIMIT LIMIT

Julia P Gregory Ownership Network

Ownership Network List of Julia P Gregory

No Data

Ownership Network Relation of Julia P Gregory

Insider Network Chart

Julia P Gregory Owned Company Details

What does Nurix Therapeutics Inc do?

Who are the key executives at Nurix Therapeutics Inc?

Julia P Gregory is the director of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include General Counsel Christine Ring , Chief Financial Officer Houte Hans Van , and Chief Scientific Officer Gwenn Hansen .

Nurix Therapeutics Inc (NRIX) Insider Trades Summary

Over the past 18 months, Julia P Gregory made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 67,327 shares made by Christine Ring , a net sale of 82,022 shares made by Houte Hans Van , and a net sale of 14,703 shares made by Gwenn Hansen .

In summary, during the past 3 months, insiders sold 70,553 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 70,553 shares. During the past 18 months, 164,052 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 164,052 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nurix Therapeutics Inc Insider Transactions

No Available Data

Julia P Gregory Mailing Address

Above is the net worth, insider trading, and ownership report for Julia P Gregory. You might contact Julia P Gregory via mailing address: 8800 Technology Forest Place, The Woodlands Tx 77381.